top of page

PRODUCTS

Cancer drug Apalutamide Apaluside for prostrate cancer

Apaluside (Apalutamide) is one of the best medications that is used to treat prostate cancer. It is an androgen receptor inhibitor. Apalutamide works by blocking the action of androgens (male hormones) on prostate cancer cells, which can slow the growth and spread of cancer. Know more.

cancer drug Degarelix, Degapt, advanced prostrate cancer, harmone therapy

Degarelix is used for the treatment of advanced prostate cancer. It is a type of gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the action of GnRH in the body. GnRH is a hormone that stimulates the production of testosterone in the testicles, and testosterone is known to promote the growth and spread of prostate cancer. Know more.

Rucaparib Rucaven, Cancer Drug, Parp inhibitor, Oncology drug, used in ovarian cancer

Rucaven (Rucaparib) is a novel drug used for the treatment of ovarian cancer. It is a type of PARP inhibitor, which works by blocking the activity of an enzyme called poly (ADP-ribose) polymerase (PARP), which helps repair damaged DNA in cells. By blocking PARP, Rucaparib can help prevent cancer cells from repairing their DNA, which can lead to their death. Know more.

Fulvestrant, Fulveside, Breast cancer medication and metastatic breast cancer medication, estrogen receptor.

Fulvestrant is a Hormonal medication used to treat hormone receptor-positive metastatic breast cancer. It is prescribed as Mono-therapy, combination therapy, and adjuvant therapy. Fulvestrant is a type of estrogen receptor antagonist and selective estrogen receptor degrader (SERD), which works by blocking the activity of estrogen in the body. Hormone receptor-positive breast cancer is characterized by the presence of estrogen and/or progesterone receptors on the surface of cancer cells, which allow the cancer cells to grow and multiply in response to these hormones. Know more.

Screenshot 2024-04-22 at 2.01.26 PM.png

Eltrocib is used to treat low platelet levels in patients with chronic immune ITP (idiopathic thrombocytopenia purpura) or who have chronic hepatitis C. It may also be used to treat patients with Aplastic Anemia. Eltrocib works by stimulating the bone marrow to produce  more platelets. It is thrombopoietin receptor agonist (TPO-RA) that works by binding to the transmembrane domain of thrombopoietin receptor. This binding activates signaling cascades that promote the proliferation and differentiation of bone marrow progenitor cells, which increases platelet production.

Screenshot 2023-10-26 at 12.00.22 PM.png
Screenshot 2024-05-02 at 9.53.40 AM.png

Brcarib is a PARP inhibitor. Indicated in advanced Ovarian Cancer typically used after chemotherapy in women with BRCA Mutation. Brcarib inhibits Poly ADP- ribose polymerase (PARP), a protein that helps repair damaged DNA in cells, by preventing PARP from repairing DNA, hence can kill cancer cells.

Screenshot 2023-10-26 at 12.00.22 PM.png
9A947B4C-CCB6-4D0B-92B7-93F62EF471A5.jpeg

Relucien (Relugolix) is used to treat advanced prostate cancer in adult men. Relugolix is a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone produced by the body. This may slow or stop the spread of prostate cancer cells that need testosterone to grow.

Acalabrutinib, Acalaside, luekemia lymphoma hematology drug cll sll cml

Acalabrutinib belongs to the class of drugs known as Bruton's tyrosine kinase (BTK) inhibitors. It is used for the treatment of certain types of cancer, specifically mantle cell lymphoma and chronic lymphocytic leukemia.

Acalabrutinib works by blocking the activity of the BTK enzyme, which is involved in the growth and survival of cancer cells. By inhibiting BTK, acalabrutinib can slow down or stop the growth and spread of cancer cells, potentially leading to remission or extended survival. Know more.

palbociclib palside , breast cancer, CDK inhibitor, Oncology medication

Palbociclib is a novel cyclin-dependent kinase (CDK) inhibitor that works by blocking the activity of CDK4 and CDK6, two enzymes that play a key role in cell division and proliferation. By inhibiting CDK4/6 activity, palbociclib can slow down or stop the growth of cancer cells, potentially leading to remission or extended survival. Know more.

Screenshot 2023-03-17 at 3.31_edited.jpg

Isavuconazole is a novel medication used as primary and secondary prophylaxis in cancer therapy. It is also used in the treatment of invasive aspergillosis and invasive mucormycosis, two serious and potentially life-threatening fungal infections. It is an antifungal agent that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. know more.

Screenshot 2023-10-26 at 12.52.05 PM.png

Isavuconazole is a novel medication used as primary and secondary prophylaxis in cancer therapy. It is also used in the treatment of invasive aspergillosis and invasive mucormycosis, two serious and potentially life-threatening fungal infections. It is an antifungal agent that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Isavuconazole in capsule form have 98% oral bioavailability. Often used for maintenance doses. know more.

Screenshot 2023-10-26 at 12.00.22 PM.png
carfican carfilzomib

Carfilzomib is a medication used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It belongs to a class of drugs known as proteasome inhibitors. It works by inhibiting the proteasome. It is typically used in combination with other medications for the treatment of multiple myeloma. The specific treatment regimen, dosage, and duration of treatment are determined by a patient's healthcare provider based on their individual circumstances and the stage of their cancer. know more

Screenshot 2023-10-26 at 12.00.31 PM.png

Pazopanib is a Multiple tyrosine kinase inhibitor. It is used in adults in the treatment of advance Renal Cell Carcinoma (RCC), Adults with advanced soft tissue sarcoma(STS) that have received prior chemotherapy. Pazopanib works against  tyrosine kinase enzymes that are responsible for cell proliferation, differentiation and migration. know more

Screenshot 2023-10-26 at 12.00.12 PM.png

Cabozantinib is a Multiple Tyrosine Kinase Inhibitor . It is used in adults with Renal Cell Carcinoma(RCC) in combination with Nivolumab. Or as first line treatment in patients with Advance Renal Cell Carcinoma.  Cabozantinib works against tyrosine kinase enzymes that are responsible for cell proliferation, differentiation and migration. know more

bottom of page